Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United States, 2019–2024 - Top-Institutions - MDSpire

Patterns of Treatment and Outcomes for Patients Diagnosed with Metastatic Pancreatic Adenocarcinoma in the United States, 2019–2024

  • By

  • Rupali Fuldeore

  • Chia Jie Tan

  • Tomomi Kimura

  • Pegah Farrokhi

  • Rachel Yang

  • Connor Willis

  • Carl Asche

  • David Stenehjem

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Diego
    University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Oncology

  • #2

    Flatiron Health Research Database
    Flatiron Health Research Database

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Northwestern Medicine
    Northwestern Medicine

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #4

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology

Original Source(s)

Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United States, 2019–2024

  • by Rupali Fuldeore, Chia Jie Tan, Tomomi Kimura, Pegah Farrokhi, Rachel Yang, Connor Willis, Carl Asche, David Stenehjem

  • July 20, 2026

Related Content

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

Global research trends and emerging frontiers of intratumoral microbiota in cancer immunotherapy: a bibliometric and visualization analysis

Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management